Patent Applications published on Oct 19, 2023 - page 4

#901 ✅ Patent 12,115,136 granted on 2024-10-15
US20230330038A1
Human necessities

Fortified CBD oil for treatment of PTSD

#902
US20230330039A1
Human necessities

FOOD SUPPLEMENT AND FOOD

#903
US20230330040A1
Human necessities

IMMUNOLOGICAL EFFECTS OF METABOLITES

#904
US20230330041A1
Human necessities

APPLICATION OF TRIS (HYDROXYMETHYL) AMINOMETHANE PHARMACEUTICALLY ACCEPTABLE SALT TO DRUGS FOR TREATING HYPERURICEMIA

#905
US20230330042A1
Human necessities

FORMULATION FOR ORAL ADMINISTRATION

#906 ✅ Patent 12,239,615 granted on 2025-03-04
US20230330043A1
Human necessities

Hydroxynorketamine for the use in the treatment of depression

#907
US20230330044A1
Human necessities

METHODS AND COMPOSITIONS FOR INTERFERING WITH EXTRACTION OR CONVERSION OF A DRUG SUSCEPTIBLE TO ABUSE

#908
US20230330045A1
Human necessities

THE ANTIVIRAL DRUG TILORONE IS A POTENT AND SELECTIVE INHIBITOR OF ACETYLCHOLINESTERASE

#909
US20230330046A1
Human necessities

TARGETING OCULAR DISEASES WITH NOVEL APE1/REF-1 INHIBITORS

#910 ✅ Patent 12,357,597 granted on 2025-07-15
US20230330047A1
Human necessities

DISPERSIBLE FORMULATIONS OF N-((R)-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2- FLUORO-4-IODO-PHENYLAMINO)-BENAZMIDE AND USES THEREOF

#911 ✅ Patent 11,850,223 granted on 2023-12-26
US20230330048A1
Human necessities

Methods of treatment of cholestatic diseases

#912
US20230330049A1
Human necessities

COMPOSITIONS AND METHODS OF USE OF GAMMA-KETOALDHEYDE SCAVENGERS FOR TREATING, PREVENTING OR IMPROVING FIBROSIS OF THE LIVER

#913
US20230330050A1
Human necessities

Methods and Compositions for Diagnosis and Treatment of Disorders in Pets

#914
US20230330051A1
Human necessities

METHOD FOR MODULATING WEIGHT

#915
US20230330052A1
Human necessities

COMPOSITION OF ACTIVE AGENTS TO POSITIVELY AFFECT A ROBUST MAMMALIAN ENDOCANNABINOID SYSTEM TONE TO BETTER ADDRESS AGE RELATED DISCOMFORT

#916
US20230330053A1
Human necessities

METHOD FOR TREATING INFECTIONS

#917
US20230330054A1
Human necessities

METHOD FOR PREVENTING OR TREATING LUNG INFECTION AND LUNG INFLAMMATION

#918
US20230330055A1
Human necessities

METHOD FOR ACTIVATING FOLLICLES BY MEANS OF USING SMALL-MOLECULE COMPOUND, AND PREPARATION THEREOF

#919
US20230330056A1
Human necessities

SEMIFLUORINATED ALKANE COMPOSITIONS

#920
US20230330057A1
Human necessities

COMPOSITIONS AND METHODS FOR PROMOTING SLEEP

#921
US20230330058A1
Human necessities

SENOLYTIC COMPOUNDS AND COMPOSITIONS

#922
US20230330059A1
Human necessities

3-PHENYL-2H-CHROMENE DERIVATIVE AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ALZHEIMER'S, CONTAINING SAME

#923
US20230330060A1
Human necessities

COMPOUNDS FOR TREATMENT OF HEART FAILURE

#924
US20230330061A1
Human necessities

ANTIMICROBIAL COMPOSITIONS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF

#925
US20230330062A1
Human necessities

PTGDR-1 AND/OR PTGDR-2 ANTAGONISTS FOR PREVENTING AND/OR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS

#926
US20230330063A1
Human necessities

COMBINATION PRODUCT FOR THE TREATMENT OF NEUROLOGICAL AND/OR PSYCHIATRIC DISORDERS

#927
US20230330064A1
Human necessities

TYROSINE, TRYPTOPHAN AND PHENYLALANINE AS mTOR AGONISTS MEDIATING PROTEASOME DYNAMICS, COMPOSITIONS, METHODS AND USES THEREOF IN THERAPY, AND PROGNOSTIC METHODS FOR DRUG-RESISTANCE

#928
US20230330065A1
Human necessities

RelA Inhibitors for Biofilm Disruption

#929
US20230330066A1
Human necessities

Vasodilator and Use Thereof

#930
US20230330067A1
Human necessities

NOVEL THIOHYDANTOIN DERIVATIVES AND USES THEREOF

#931
US20230330068A1
Human necessities

GEL COMPOSITION OF LULICONAZOLE FOR TREATMENT OF VAGINAL FUNGAL INFECTIONS AND ITS MANUFACTURING PROCESS

#932
US20230330069A1
Human necessities

USE OF THIAZOLIDES AGAINST CORONAVIRUSES

#933
US20230330071A1
Human necessities

METHODS OF TREATING HEPATIC ENCEPHALOPATHY

#934 ✅ Patent 11,857,542 granted on 2024-01-02
US20230330072A1
Human necessities

Treatment of migraine

#935
US20230330073A1
Human necessities

USE OF PRIDOPIDINE FOR TREATING FUNCTIONAL DECLINE

#936
US20230330074A1
Human necessities

COMPOUNDS AND METHODS FOR TREATING SPASTICITY

#937 ✅ Patent 12,285,417 granted on 2025-04-29
US20230330075A1
Human necessities

Methods for treating chronic obstructive pulmonary disease

#938
US20230330076A1
Human necessities

CONTROLLED RELEASE FORMULATIONS OF FLAVOXATE AND PROCESS FOR PREPARATION THEREOF

#939
US20230330077A1
Human necessities

USE OF SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST

#940
US20230330078A1
Human necessities

METHODS FOR THE ADMINISTRATION OF ILOPERIDONE

#941
US20230330079A1
Human necessities

ORALLY-DISINTEGRATING FILM COMPRISING NARATRIPTAN

#942
US20230330080A1
Human necessities

THERAPEUTIC TREATMENT USING PROTEIN KINASE C (PKC) INHIBITORS AND CYTOTOXIC AGENTS

#943
US20230330081A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR TREATING TUMORS

#944
US20230330083A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING PULMONARY HYPERTENSION

#945 ✅ Patent 12,226,412 granted on 2025-02-18
US20230330084A1
Human necessities

Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

#946
US20230330085A1
Human necessities

LSD DOSE IDENTIFICATION

#947 ✅ Patent 12,186,311 granted on 2025-01-07
US20230330086A1
Human necessities

Antiproliferative compounds and second active agents for combined use

#948 ✅ Patent 12,233,058 granted on 2025-02-25
US20230330087A1
Human necessities

Methods of treating non-obstructive hypertrophic cardiomyopathy using modified forms of trimetazidine

#949
US20230330088A1
Human necessities

COMBINATION THERAPY FOR TREATING ABNORMAL CELL GROWTH

#950
US20230330089A1
Human necessities

COVID PREVENTION AND TREATMENT USING AN INTEGRIN INHIBITOR

#951
US20230330090A1
Human necessities

Compositions Comprising Lithium Orotate And L-Leucine And Methods For Improving Cognitive Performance

#952
US20230330091A1
Human necessities

Method of Adjuvant Cancer Treatment

#953 ✅ Patent 12,336,997 granted on 2025-06-24
US20230330092A1
Human necessities

METHODS FOR TREATING CONGENITAL EPIDERMAL HYPERPLASIA AND COMPOSITIONS FOR SAME

#954
US20230330093A1
Human necessities

APPLICATION OF NITROGEN-CONTAINING SATURATED HETEROCYCLIC COMPOUND

#955
US20230330094A1
Human necessities

COMBINATION COMPOSITIONS AND METHODS FOR TREATING CANCER

#956
US20230330095A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR ANTI-CANCER COMPRISING NUPR1 ISOFORM A INHIBITOR

#957 ✅ Patent 12,343,349 granted on 2025-07-01
US20230330096A1
Human necessities

IMIPRAMINE FOR USE AS AN INHIBITOR OF FASCIN1 OVEREXPRESSION

#958 ✅ Patent 12,070,465 granted on 2024-08-27
US20230330097A1
Human necessities

Compositions and methods for the prevention and treatment of hearing loss

#959
US20230330098A1
Human necessities

USE OF FENOLDOPAM FOR THE TREATMENT OF HEMOLYTIC UREMIC SYNDROME

#960 ✅ Patent 12,144,816 granted on 2024-11-19
US20230330099A1
Human necessities

Substituted indole Mcl-1 inhibitors

#961
US20230330100A1
Human necessities

TASTE-MASKING ORAL FORMULATIONS OF FASUDIL

#962 ✅ Patent 11,944,633 granted on 2024-04-02
US20230330101A1
Human necessities

Oral formulations of fasudil with ion exchange resin

#963
US20230330102A1
Human necessities

PROTAC ANTIBODY CONJUGATES AND METHODS OF USE

#964
US20230330103A1
Human necessities

NON-PEPTIDE OXYTOCIN RECEPTOR AGONISTS

#965
US20230330104A1
Human necessities

PRESERVATIVE-FREE OPHTHALMIC PHARMACEUTICAL EMULSION AND ITS APPLICATION

#966
US20230330105A1
Human necessities

METHODS AND COMPOSITIONS FOR TOPICAL DELIVERY OF PROSTAGLANDINS TO SUBCUTANEOUS FAT

#967 ✅ Patent 12,083,129 granted on 2024-09-10
US20230330106A1
Human necessities

Treatment of breast cancer using combination therapies comprising an ATP competitive AKT inhibitor, a CDK4/6 inhibitor, and fulvestrant

#968
US20230330107A1
Human necessities

METHODS TO PREVENT HIGH-GRADE SEROUS OVARIAN CANCER AND BREAST CANCER BY ADMINISTERING ANTIPROGESTINS

#969
US20230330108A1
Human necessities

MULTIPHASIC CONTRACEPTIVE REGIMEN FOR ORAL COMBINATION DRUG FORMULATION OF PROGESTIN AND ESTROGEN

#970
US20230330109A1
Human necessities

COMPOUND FOR PREVENTING AND TREATING LIVER DISEASES AND PHARMACEUTICAL USE THEREOF

#971
US20230330110A1
Human necessities

HARD CAPSULE DOSAGE FORM AND USES THEREOF

#972
US20230330111A1
Human necessities

ACTIVE AGENT COMBINATION FOR TREATMENT OF CANCER

#973
US20230330112A1
Human necessities

COMPOSITION AND TREATMENT FOR CANCER WITH MUTATIONS

#974
US20230330113A1
Human necessities

TOPICAL COMPOSITION

#975
US20230330114A1
Human necessities

COMPOSITIONS COMPRISING MONO- AND DI-GLYCERIDES WITH OMEGA-3 FATTY ACYL GROUPS AND METHODS OF USING SAME

#976
US20230330115A1
Human necessities

COMPOSITION COMPRISING COMBINATIONS OF CANNABINOID HOMOLOGUES THCB (TETRAHYDROCANNABUTOL) AND THCP (TETRAHYDROCANNABIPHOROL)

#977
US20230330116A1
Human necessities

MATERIALS AND METHODS FOR SUPPRESSING AND/OR TREATING BONE RELATED DISEASES AND SYMPTOMS

#978 ✅ Patent 11,865,126 granted on 2024-01-09
US20230330117A1
Human necessities

Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin

#979
US20230330118A1
Human necessities

2-DEOXY-D-GLUCOSE FOR PREVENTION AND TREATMENT OF A VIRAL DISEASE, IN PARTICULAR OF COVID-19

#980 ✅ Patent 12,016,873 granted on 2024-06-25
US20230330119A1
Human necessities

Methods for treating pulmonary non-tuberculous mycobacterial infections

#981
US20230330120A1
Human necessities

COMPOSITION FOR PREVENTING HAIR LOSS OR PROMOTING HAIR REGROWTH

#982
US20230330121A1
Human necessities

COMPOSITIONS AND METHODS FOR THE TREATMENT OF BRONCHIOLITIS OBLITERANS

#983
US20230330122A1
Human necessities

PHARMACOLOGICAL TREATMENT OF AUTISM SPECTRUM DISORDER

#984
US20230330123A1
Human necessities

A NON-AQUEOUS SUSPENSION OF ANTICANCER AGENT

#985
US20230330124A1
Human necessities

NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES AND USE THEREOF IN THE TREATMENT AND PREVENTION OF A RED BLOOD CELL DISORDER

#986
US20230330125A1
Human necessities

ORAL COMPOSITION COMPRISING S-ADENOSYL METHIONINE AND A PROBIOTIC AND ITS USE FOR TREATING AND/OR PREVENTING MOOD DISORDERS

#987
US20230330126A1
Human necessities

MODIFIED ADENOSINE NUCLEOSIDE FOR USE IN THE TREATMENT OF VIRAL INFECTIONS

#988
US20230330127A1
Human necessities

6-6 BICYCLIC AROMATIC RING SUBSTITUTED NUCLEOSIDE ANALOGUES FOR USE AS PRMT5 INHIBITORS

#989
US20230330128A1
Human necessities

OLIGOMERS HAVING BICYCLIC SCAFFOLD MOIETIES

#990
US20230330129A1
Human necessities

TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY (TNFRSF) AGONISTS, SPHERICAL NUCLEIC ACID (SNA) TLR9 AGONISTS AND CHECKPOINT INHIBITORS FOR ANTITUMOR THERAPY

#991
US20230330130A1
Human necessities

VESICLES COMPRISING A PTEN INHIBITOR AND USES OF SAME

#992
US20230330131A1
Human necessities

PREBIOTIC COMPOSITION AND ITS USE

#993
US20230330132A1
Human necessities

VIRAL INHIBITORS

#994
US20230330133A1
Human necessities

METHODS FOR THE TREATMENT OF CHOLESTEROL CRYSTAL EMBOLIZATION WITH CYCLODEXTRINS

#995
US20230330134A1
Human necessities

METHOD OF PROPHYLAXIS OF CORONAVIRUS AND/OR RESPIRATORY SYNCYTIAL VIRUS INFECTION

#996
US20230330135A1
Human necessities

CARBON NANOPARTICLES SUSPENSION INJECTION-FE MIXTURE AS WELL AS PREPARATION METHOD

#997
US20230330136A1
Human necessities

BLOOD-BRAIN BARRIER-PENETRATING NANOTHERANOSTICS FOR ACUTE AND CHRONIC NEURODEGENERATIVE DISEASES AND THE LIKE

#998 ✅ Patent 12,329,779 granted on 2025-06-17
US20230330137A1
Human necessities

COPPER ION COMPOSITIONS AND METHODS OF TREATMENT FOR CONDITIONS CAUSED BY CORONAVIRUS AND INFLUENZA

#999
US20230330138A1
Human necessities

TREATMENT OF CARTILAGE DEGENERATION USING MYELOID SUPPRESSOR CELLS AND EXOSOMES DERIVED THEREOF

#1000
US20230330139A1
Human necessities

CAR T-CELLS COMPRISING AN ANTI CD33, AN ANTI CLL1 AND AT LEAST ONE FURTHER CAR ANTI CD123 AND/OR FTL3

#1001
US20230330140A1
Human necessities

IMMUNE CELL DELIVERY OF SIALIDASE CANCER CELLS, IMMUNE CELLS AND THE TUMOR MICROENVIRONMENT

#1002
US20230330141A1
Human necessities

METHODS OF PRODUCING T REGULATORY CELLS, METHODS OF TRANSDUCING T CELLS, AND USES OF THE SAME

#1003
US20230330142A1
Human necessities

COMBINATORIAL ANTIGEN RECOGNITION IN CANCER T CELL THERAPIES

#1004
US20230330143A1
Human necessities

IMMUNOTHERAPY COMPOSITION

#1005
US20230330145A1
Human necessities

NATURAL KILLER CELLS

#1006
US20230330146A1
Human necessities

APPLICATION OF MESENCHYMAL STEM CELLS IN PREPARATION OF DRUG FOR REPAIRING LUNG DAMAGE CAUSED BY COVID-19

#1007
US20230330147A1
Human necessities

ALGINATE-COATED MESENCHYMAL STROMAL AND PROGENITOR CELLS AND METHODS FOR USING THE SAME

#1008
US20230330148A1
Human necessities

METHODS OF TREATING AN ISCHEMIC DISEASE

#1009
US20230330149A1
Human necessities

ENHANCEMENT OF CARTILAGE REGENERATIVE ACTIVITY OF STEM CELL POPULATIONS BASED ON REDUCTION OF INTRA-ARTICULAR CELLULAR MATERIAL

#1010
US20230330150A1
Human necessities

MESENCHYMAL STEM CELLS FOR TREATMENT OF SKIN DISORDERS AND SKIN PROBLEMS

#1011
US20230330151A1
Human necessities

COMPOSITION FOR PROMOTING DIFFERENTIATION OF NEURAL STEM CELLS INTO DOPAMINERGIC NEURONS

#1012
US20230330152A1
Human necessities

METHODS AND COMPOSITIONS FOR GENERATING CHONDROCYTE LINEAGE CELLS AND/OR CARTILAGE LIKE TISSUE

#1013
US20230330153A1
Human necessities

ENGINEERED SKIN CONSTRUCT OVERLAY OF AUTOGRAFT

#1014
US20230330154A1
Human necessities

METHODS OF TREATING SYSTEMIC GRAFT- VERSUS-HOST DISEASE WITH EXTRACELLULAR VESICLES

#1015
US20230330155A1
Human necessities

FOLLICULAR FLUID METHOD

#1016 ✅ Patent 12,251,406 granted on 2025-03-18
US20230330156A1
Human necessities

Biopolymer compositions for the treatment and prevention of gastric ulcers

#1017
US20230330157A1
Human necessities

MODULATION OF MICROBIOTA FUNCTION BY GENE THERAPY OF THE MICROBIOME TO PREVENT, TREAT OR CURE MICROBIOME-ASSOCIATED DISEASES OR DISORDERS

#1018
US20230330158A1
Human necessities

INTESTINAL MICROBIOTA BACTERIA AND COMPOSITION CONTAINING SAME FOR USE IN THE PREVENTION AND/OR TREATMENT OF DISEASES CHARACTERISED BY EXCESS 2-HYDROXYGLUTARATE

#1019
US20230330159A1
Human necessities

COMPOSITION FOR DIAGNOSIS OR TREATMENT OF INFLAMMATORY DISEASES, COMPRISING MICROORGANISM

#1020 ✅ Patent 12,036,252 granted on 2024-07-16
US20230330160A1
Human necessities

Pairing probiotics and prebiotics, methods for growth and use, separately and in combination

#1021
US20230330161A1
Human necessities

MICROORGANISM STRAIN PEDIOCOCCUS ACIDILACTICI TAK 589 COCCOBEST AS AN ANTIMICROBIAL AND ANTIOXIDANT PROBIOTIC

#1022
US20230330162A1
Human necessities

PRODUCT COMPRISING PROBIOTICS AND ISOMALTULOSE AND METHOD OF ITS PRODUCTION

#1023
US20230330163A1
Human necessities

METHOD FOR REDUCING BEHAVIORAL ABNORMALITIES

#1024
US20230330164A1
Human necessities

COMPOSITION COMPRISING LACTOFERRIN AND PROBIOTIC BACTERIAL STRAINS FOR ORAL USE WITH ANTIVIRAL ACTION

#1025
US20230330165A1
Human necessities

MUSCLE ATROPHY PREVENTION AGENT

#1026 ✅ Patent 11,963,989 granted on 2024-04-23
US20230330166A1
Human necessities

Application of medical cell CMU-pb-7 in preparation of blood lipid-lowering drugs

#1027
US20230330167A1
Human necessities

PHAGE AND TRANSDUCTION PARTICLES

#1028
US20230330168A1
Human necessities

COMPOSITION FOR IMPROVING EYESIGHT

#1029
US20230330169A1
Human necessities

PHARMACEUTICAL COMPOSITIONS

#1030
US20230330170A1
Human necessities

COMPOSITION USED AS A MOOD-REGULATING STIMULANT

#1031
US20230330171A1
Human necessities

BOYSENBERRY COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREOF

#1032
US20230330172A1
Human necessities

COMPOSITION FOR AMELIORATING UNPLEASANT STATE CAUSED BY MENSTRUATION

#1033
US20230330173A1
Human necessities

POWDER SOLID COMPOSITIONS, PROCESS FOR THEIR PREPARATION, FORMULATIONS AND USE THEREOF

#1034 ✅ Patent 12,233,102 granted on 2025-02-25
US20230330174A1
Human necessities

Alvoecore a respiratory system protection product and immune system booster

#1035 ✅ Patent 12,076,362 granted on 2024-09-03
US20230330175A1
Human necessities

Botanical pain relief ointment

#1036
US20230330176A1
Human necessities

PHARMACEUTICAL COMBINATION COMPRISING AN IBAT INHIBITOR AND A BILE ACID BINDER

#1037 ✅ Patent 12,128,084 granted on 2024-10-29
US20230330177A1
Human necessities

Use of PAYCS in regulation of intestinal flora, metabolites, and brain neurotransmitters

#1038
US20230330178A1
Human necessities

USE OF POLYPEPTIDE IN DRUG FOR PREVENTING AND TREATING PNEUMONIA

#1039
US20230330179A1
Human necessities

COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASES AND USE THEREOF

#1040
US20230330180A1
Human necessities

ANTIVIRAL COMPOSITIONS AND METHODS

#1041
US20230330181A1
Human necessities

PEPTIDES DERIVED FROM KITA-KYUSHU LUNG CANCER ANTIGEN (KKLC1, CT83, CXORF61) AND COMPLEXES COMPRISING SUCH PEPTIDES BOUND TO MHC MOLECULES

#1042
US20230330182A1
Human necessities

COMBINED PREPARATIONS FOR THE TREATMENT OF CANCER OR INFECTION

#1043
US20230330183A1
Human necessities

STEM CELL CONDITIONED MEDIA FOR CLINICAL AND COSMETIC APPLICATIONS

#1044 ✅ Patent 12,350,315 granted on 2025-07-08
US20230330184A1
Human necessities

METHODS OF TREATING NEUTORPENIA USING G-CSF PROTEIN COMPLEX

#1045
US20230330185A1
Human necessities

METHODS AND COMPOSITIONS FOR TRANSDUCING HEMATOPOIETIC STEM AND PROGENITOR CELLS IN VIVO

#1046 ✅ Patent 12,156,901 granted on 2024-12-03
US20230330186A1
Human necessities

Treatment of immunosuppressed subjects

#1047
US20230330187A1
Human necessities

USE OF GHRELIN OR GHRELIN VARIANT FOR INCREASING DOSE INTENSITY OF CHEMOTHERAPEUTIC AGENTS IN PATIENTS WITH CANCER

#1048
US20230330188A1
Human necessities

PHARMACEUTICAL COMBINATION FOR USE IN THE TREATMENT AND/OR PREVENTION OF DIABETES

#1049
US20230330189A1
Human necessities

ACYLATED GLP-1 DERIVATIVE

#1050
US20230330190A1
Human necessities

TOPICAL COMPOSITION FOR IMPROVED HEALING OF OPEN WOUNDS

#1051
US20230330191A1
Human necessities

METHODS OF STIMULATING BONE GROWTH WITH ABALOPARATIDE AND DENOSUMAB

#1052
US20230330192A1
Human necessities

METHODS OF USING POLYMERIZED HUMAN SERUM ALBUMIN

#1053
US20230330193A1
Human necessities

ENHANCEMENT OF STEM CELL THERAPY FOR CARTILAGE DEGENERATION BY ANTI-OXIDANT PRE-CONDITIONING

#1054
US20230330194A1
Human necessities

METHODS OF CYTOTOXIC GENE THERAPY TO TREAT TUMORS

#1055
US20230330195A1
Human necessities

METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROLOGIC DISEASE

#1056
US20230330196A1
Human necessities

IMMUNOSUPPRESSIVE AGENTS

#1057
US20230330197A1
Human necessities

MHC CLASS II T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF

#1058
US20230330198A1
Human necessities

RNA FOR TREATMENT OF AUTOIMMUNE DISEASES

#1059
US20230330199A1
Human necessities

TARGETING DELIVERY SYSTEM LOADED WITH WHOLE-CELL COMPONENTS AND USE THEREOF

#1060
US20230330200A1
Human necessities

NY-ESO-1-CONTAINING ARTIFICIAL ADJUVANT VECTOR CELL FOR USE IN TREATMENT OF CANCER

#1061
US20230330201A1
Human necessities

COMPOSITIONS FOR USE AS A PROPHYLACTIC AGENT TO THOSE AT RISK OF INFECTION OF TUBERCULOSIS, OR AS SECONDARY AGENTS FOR TREATING INFECTED TUBERCULOSIS PATIENTS

#1062
US20230330202A1
Human necessities

NANOEMULSION AND METHODS OF USE THEREOF

#1063
US20230330203A1
Human necessities

MICROPARTICLES FROM STREPTOCOCCUS PNEUMONIAE AS VACCINE ANTIGENS

#1064 ✅ Patent 12,214,031 granted on 2025-02-04
US20230330204A1
Human necessities

vector

#1065
US20230330205A1
Human necessities

NOROVIRUS VACCINE

#1066
US20230330207A1
Human necessities

CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY

#1067
US20230330208A1
Human necessities

Immunogenic Human Rhinovirus (HRV) Composition

#1068
US20230330209A1
Human necessities

TREATMENT OF INFLAMMATORY CONDITIONS

#1069 ✅ Patent 11,969,466 granted on 2024-04-30
US20230330210A1
Human necessities

Stabilized influenza hemagglutinin stem region trimers and uses thereof

#1070
US20230330211A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING CORONAVIRUSES

#1071
US20230330213A1
Human necessities

COMPOSITIONS OF SARS-COV-2 VACCINES BASED ON THE RECEPTOR BINDING DOMAIN, EXPRESSED AS A DIMER, AND THE OUTER MEMBRANE VESICLE OF MENINGOCOCCAL GROUP B BACTERIA

#1072
US20230330214A1
Human necessities

IMPROVED DNA VACCINE FOR SARS-COV-2

#1073
US20230330215A1
Human necessities

SARS-COV-2 VACCINES

#1074
US20230330216A1
Human necessities

CORONAVIRUS VACCINE FORMULATIONS

#1075
US20230330217A1
Human necessities

Herpes 1 Antibody System

#1076
US20230330218A1
Human necessities

HEPATITIS C VIRUS MODIFIED E2 GLYCOPROTEIN AND USES THEREOF AS VACCINES

#1077
US20230330219A1
Human necessities

NUCLEIC ACID NANOSTRUCTURE PLATFORM FOR PROGRAMMING IMMUNE STIMULATION

#1078
US20230330220A1
Human necessities

METHOD FOR IMPROVING IMMUNOGENICITY OF PROTEIN/PEPTIDE ANTIGEN

#1079 ✅ Patent 12,016,920 granted on 2024-06-25
US20230330221A1
Human necessities

Adjuvant based on peptide nucleic acid

#1080
US20230330222A1
Human necessities

SELECTIVE TARGETING OF THE TREML1/MD2 INTERACTION BY SMALL PEPTIDE OR PROTEIN AND ITS USE FOR VACCINE ADJUVANTS

#1081
US20230330223A1
Human necessities

TREATMENT OF HER2 NEGATIVE, MAMMAPRINT HIGH RISK 2 BREAST CANCER

#1082
US20230330224A1
Human necessities

Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Bortezomib and Dexamethasone

#1083 ✅ Patent 12,246,066 granted on 2025-03-11
US20230330225A1
Human necessities

Anti-CTLA-4 antibodies and methods of use thereof

#1084
US20230330226A1
Human necessities

COMPOSITIONS AND METHODS FOR THE PREVENTION OF TYPE I HYPERSENSITIVITY REACTIONS

#1085
US20230330227A1
Human necessities

GENE FUSIONS FOR CONTROL OF GENETICALLY MODIFIED CELLS

#1086
US20230330228A1
Human necessities

HYBRID PROMOTERS, VECTORS CONTAINING SAME AND METHODS OF USE

#1087
US20230330229A1
Human necessities

METHODS FOR IMAGE-GUIDED RADIOTHERAPY

#1088
US20230330230A1
Human necessities

SENSITISER FOR CANCER TREATMENT

#1089
US20230330231A1
Human necessities

Process for cure of MI's and strokes through drug induced biophysical methods.

#1090
US20230330232A1
Human necessities

SELF-ASSEMBLED COMPLEX CONTAINING IRON ION

#1091
US20230330233A1
Human necessities

COMPOSITIONS AND METHODS FOR DELIVERING PHARMACEUTICAL AGENTS

#1092
US20230330234A1
Human necessities

HYPERBRANCHED POLYESTER POLYOL DERIVATIVE AS DRUG SOLUBILIZER

#1093
US20230330235A1
Human necessities

T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF

#1094
US20230330236A1
Human necessities

CERVIDAE DEER FAMILY ANTLER PET CHEW WITH HEALTH ADDITIVES AND METHOD OF USE AND MAKING

#1095
US20230330237A1
Human necessities

MODULATORS OF NUCLEAR RECEPTOR SUBFAMILY 4 GROUP A MEMBER 1 (NR4A1) AND USES THEREOF

#1096
US20230330238A1
Human necessities

CHIMERIC CONJUGATES FOR DEGRADATION OF VIRAL AND HOST PROTEINS AND METHODS OF USE

#1097
US20230330239A1
Human necessities

EPCAM BINDING FIBRONECTIN TYPE III DOMAINS

#1098
US20230330240A1
Human necessities

TECHNOLOGIES FOR PREVENTING OR TREATING INFECTIONS

#1099
US20230330241A1
Human necessities

HUMANIZED ANTI-LIV1 ANTIBODIES FOR THE TREATMENT OF CANCER

#1100 ✅ Patent 11,806,405 granted on 2023-11-07
US20230330242A1
Human necessities

Immunoconjugates and methods

#1101
US20230330243A1
Human necessities

COMBINATION OF ANTIBODY-DRUG CONJUGATE AND ATR INHIBITOR

#1102
US20230330244A1
Human necessities

NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) INHIBITOR-CONJUGATES AND USES THEREOF

#1103
US20230330245A1
Human necessities

ANTIBODY-EXATECAN CONJUGATES

#1104
US20230330246A1
Human necessities

COMPOSITIONS AND METHODS OF TREATING POMPE DISEASE

#1105 ✅ Patent 11,931,421 granted on 2024-03-19
US20230330247A1
Human necessities

Muscle targeting complexes and formulations for treating myotonic dystrophy

#1106
US20230330248A1
Human necessities

ANTIBODY-DRUG CONJUGATE INCLUDING NOVEL CYCLIC DINUCLEOTIDE DERIVATIVE

#1107
US20230330249A1
Human necessities

ANTIBODY-CONJUGATED CHEMICAL INDUCERS OF DEGRADATION OF BRM AND METHODS THEREOF

#1108
US20230330251A1
Human necessities

METHODS FOR TREATING CANCERS WITH ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 191P4D12 PROTEINS

#1109
US20230330252A1
Human necessities

CONJUGATE AND PHOTOIMMUNOTHERAPY

#1110 ✅ Patent 12,324,936 granted on 2025-06-10
US20230330253A1
Human necessities

ANTIBODY-DRUG CONJUGATES TARGETING CLAUDIN 18.2

#1111
US20230330254A1
Human necessities

ANTI-GLP1R ANTIBODY-TETHERED DRUG CONJUGATES COMPRISING GLP1 PEPTIDOMIMETICS AND USES THEREOF

#1112
US20230330257A1
Human necessities

DEVELOPMENT OF DRUG THERAPEUTIC AGENT CONTAINING ADAPTOR AND USE THEREOF

#1113
US20230330258A1
Human necessities

CONJUGATES COMPRISING A PHOSPHORUS (V) AND A DRUG MOIETY

#1114
US20230330259A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR RELATED DISORDERS

#1115
US20230330260A1
Human necessities

RNA FORMULATIONS

#1116
US20230330261A1
Human necessities

SELF-ASSEMBLED COMPLEX CONTAINING COPPER IONS

#1117 ✅ Patent 11,951,181 granted on 2024-04-09
US20230330262A1
Human necessities

Lipid nanoparticle compositions and methods for mRNA delivery

#1118
US20230330263A1
Human necessities

PLAKOPHILLIN-2 GENE THERAPY METHODS AND COMPOSITIONS

#1119
US20230330264A1
Human necessities

COMPOSITIONS AND METHODS FOR EXOSOME-MEDIATED DELIVERY OF mRNA AGENTS

#1120
US20230330265A1
Human necessities

GENE THERAPY VECTOR FOR eEF1A2 AND USES THEREOF

#1121
US20230330266A1
Human necessities

GENE THERAPY FOR LIPODYSTROPHY

#1122
US20230330267A1
Human necessities

NOVEL ENGINEERED CAPSID SEROTYPE OF RECOMBINANT ADENO-ASSOCIATED VIRAL VECTOR WITH ENHANCED TRANSDUCTION EFFICIENCY AND WIDESPREAD DISTRIBUTION IN THE BRAIN

#1123
US20230330268A1
Human necessities

MATERIALS AND METHODS FOR DELIVERING NUCLEIC ACIDS TO COCHLEAR AND VESTIBULAR CELLS

#1124
US20230330269A1
Human necessities

TREATMENT OF RPE65-ASSOCIATED EYE DISEASES AND DISORDERS

#1125
US20230330270A1
Human necessities

MATERIALS AND METHODS FOR TREATMENT OF FRIEDREICH ATAXIA AND OTHER RELATED DISORDERS

#1126
US20230330271A1
Human necessities

THROMBUS IMAGING APTAMERS AND METHODS OF USING SAME

#1127
US20230330272A1
Human necessities

COMPOUND AND MRI CONTRAST AGENT CONTAINING SAME

#1128
US20230330273A1
Human necessities

MAGNETIC NANOPARTICLES FUNCTIONALIZED WITH CATHECOL, PRODUCTION AND USE THEREOF

#1129
US20230330274A1
Human necessities

METHODS FOR MAKING ULTRASOUND CONTRAST AGENTS

#1130
US20230330275A1
Human necessities

FAP-TARGETED RADIOPHARMACEUTICALS AND IMAGING AGENTS, AND USES RELATED THERETO

#1131
US20230330276A1
Human necessities

FORMULATIONS AND KITS FOR RADIOTHERAPY AND DIAGNOSTIC IMAGING

#1132
US20230330277A1
Human necessities

Radioisotope and Aptamer Drug Combination to treat S. aureus and E. coli infections

#1133
US20230330278A1
Human necessities

METHODS FOR RADIOLABELLING PSMA BINDING LIGANDS AND THEIR KITS

#1134
US20230330280A1
Human necessities

PREPARATIONS OF RADIUM-224 AND PROGENIES FOR USE IN RADIONUCLIDE THERAPY IN COMBINATION WITH DNA REPAIR INHIBITORS

#1135
US20230330281A1
Human necessities

LIGHT AND DISINFECTION SYSTEM WITH COINCIDENT ILLUMINATION RANGE

#1136
US20230330282A1
Human necessities

SYSTEM AND METHOD FOR ULTRAVIOLET STERILIZATION OF FLUIDS

#1137
US20230330283A1
Human necessities

DECONTAMINATION BACKPACK SYSTEM

#1138
US20230330284A1
Human necessities

DISINFECTING DEVICE INCLUDING ROTATING CHAMBER BASE

#1139
US20230330285A1
Human necessities

SELF-CLEANING DOMESTIC APPLIANCE

#1140 ✅ Patent 12,214,097 granted on 2025-02-04
US20230330286A1
Human necessities

Disinfecting methods and apparatus

#1141
US20230330287A1
Human necessities

MEDICAL DEVICE STERILIZATION SYSTEM WITH PLASMA-BASED DETECTION OF RESIDUAL ALCOHOL

#1142
US20230330288A1
Human necessities

MEDICAL PROBE STERILIZER

#1143 ✅ Patent 12,128,152 granted on 2024-10-29
US20230330289A1
Human necessities

System and method for injection and retraction of fluid

#1144 ✅ Patent 12,194,180 granted on 2025-01-14
US20230330290A1
Human necessities

Ozone disinfection device, ozone disinfection system, and ozone disinfection method

#1145
US20230330291A1
Human necessities

CHEMICAL SPRAYING SYSTEM AND METHOD FOR OPERATING SAME

#1146
US20230330292A1
Human necessities

AUTOMATIC OBJECT DATA DISPENSING INSERTION SYSTEM

#1147
US20230330293A1
Human necessities

SELF-CLEANING VACUUM CLEANER

#1148
US20230330294A1
Human necessities

Odorant capsule and adaptable olfactory composition carrier for a device for emitting such a composition, kit for emitting an olfactory composition and its use

#1149
US20230330295A1
Human necessities

REMOTE SMELL TECHNOLOGY

#1150
US20230330296A1
Human necessities

SPACE CLEANING DEVICE AND SPACE CLEANING SYSTEM USING SAME

#1151
US20230330297A1
Human necessities

HOMEOSTATIC SINGLE LAYER DRESSING

#1152
US20230330298A1
Human necessities

Aromatherapeutic Honey Bandage

#1153
US20230330299A1
Human necessities

LONG-ACTING SUPERHYDROPHOBIC ANTICOAGULATION BIOLOGICAL VALVE AND PREPARATION METHOD THEREFOR

#1154
US20230330300A1
Human necessities

FOLD RESISTANT DEHYDRATED CROSS-LINKED BIOLOGICAL MATERIAL, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

#1155 ✅ Patent 12,296,068 granted on 2025-05-13
US20230330301A1
Human necessities

Therapeutic putties containing additives including processed human blood plasma

#1156
US20230330302A1
Human necessities

ORTHOPEDIC REPAIR SCAFFOLD, PREPARATION METHOD THEREOF AND USE THEREOF

#1157
US20230330303A1
Human necessities

SURFACE ALLOYED MEDICAL IMPLANT

#1158
US20230330304A1
Human necessities

GEL MATERIAL FOR TREATING TENDON OR LIGAMENT

#1159
US20230330305A1
Human necessities

HYDROGEL COMPRISING A CROSS-LINKED AND SILYLATED POLYSACCHARIDE AND PROCESS FOR OBTAINING SAME

#1160
US20230330306A1
Human necessities

PRO-ENDOTHELIALIZATION BIOLOGICAL MATERIAL, HEART VALVE, AND PREPARATION AND APPLICATION THEREOF

#1161
US20230330307A1
Human necessities

COMPOSITIONS AND METHODS FOR INHIBITING VASCULAR SMOOTH MUSCLE CELL PROLIFERATION

#1162
US20230330308A1
Human necessities

Articles, compositions, and methods for sutureless implants

#1163 ✅ Patent 11,975,125 granted on 2024-05-07
US20230330309A1
Human necessities

Medical devices

#1164
US20230330310A1
Human necessities

WEARABLE HEMOFILTRATION ARTIFICIAL KIDNEY

#1165
US20230330311A1
Human necessities

DEVICE AND METHOD FOR DETERMINATION OF A CO2 PARTIAL PRESSURE VALUE ON A BLOOD SIDE OF AN OXYGENATOR

#1166
US20230330312A1
Human necessities

EXTRACORPOREAL OXYGENATOR WITH INTEGRATED AIR REMOVAL SYSTEM

#1167
US20230330313A1
Human necessities

PERITONEAL DIALYSIS SYSTEM AND METHOD FOR MINIMIZING PATIENT DRAIN PAIN

#1168 ✅ Patent 12,318,523 granted on 2025-06-03
US20230330314A1
Human necessities

Method for identifying the type of a medical filter, and apparatuses

#1169
US20230330315A1
Human necessities

APPARATUS FOR EXTRACORPOREAL BLOOD TREATMENT AND METHOD FOR ADMINISTERING NUTRITIONAL PRODUCTS IN AN APPARATUS FOR EXTRACORPOREAL BLOOD TREATMENT

#1170 ✅ Patent 11,969,542 granted on 2024-04-30
US20230330316A1
Human necessities

System and apparatus for preventing therapy unit contamination

#1171
US20230330317A1
Human necessities

Large Capacity Manifold For A Medical/Surgical Waste Collection System

#1172 ✅ Patent 12,370,301 granted on 2025-07-29
US20230330318A1
Human necessities

SUCTION AND IRRIGATION DEVICE

#1173
US20230330319A1
Human necessities

A NEGATIVE PRESSURE WOUND THERAPY (NPWT) DRESSING

#1174
US20230330320A1
Human necessities

CONTROL ARCHITECTURE FOR REDUCED PRESSURE WOUND THERAPY APPARATUS

#1175
US20230330321A1
Human necessities

REDUCED PRESSURE THERAPY APPARATUSES AND METHODS OF USING SAME

#1176
US20230330322A1
Human necessities

DEVICE FOR MOTORIZING THE MOVEMENTS OF THE PISTON OF A FLUID TANK USED IN THE MEDICAL ENVIRONMENT

#1177
US20230330323A1
Human necessities

LONG-TERM MEDICAMENT STORAGE APPARATUS AND METHODS

#1178 ✅ Patent 12,201,808 granted on 2025-01-21
US20230330324A1
Human necessities

Automated insertion assembly

#1179
US20230330325A1
Human necessities

DRUG DELIVERY DEVICE WITH ELECTROMAGNETIC DRIVE UNIT

#1180
US20230330326A1
Human necessities

ELECTROOSMOTIC PUMP, INSULIN PUMP AND INSULIN PUMP SYSTEM

#1181
US20230330327A1
Human necessities

PATCH INJECTION PUMP

#1182
US20230330328A1
Human necessities

SYSTEMS AND DEVICES FOR CONTROLLED DRUG DELIVERY

#1183
US20230330329A1
Human necessities

SYSTEMS AND METHODS FOR DELIVERING MICRODOSES OF MEDICATION

#1184
US20230330330A1
Human necessities

UNILATERALLY DRIVEN DRUG INFUSION SYSTEM

#1185
US20230330331A1
Human necessities

INSERTION DEVICE WITH LINKAGE ASSEMBLY

#1186
US20230330332A1
Human necessities

PRESSURE TRANSDUCER FOR INJECTIONS

#1187
US20230330333A1
Human necessities

DRIVING STRUCTURE OF A DRUG INFUSION DEVICE

#1188
US20230330334A1
Human necessities

SYSTEMS, DEVICES AND RELATED METHODS OF INSULIN MANAGEMENT FOR DELIVERING INSULIN DURING A FASTING PERIOD

#1189
US20230330335A1
Human necessities

SYSTEMS, DEVICES AND RELATED METHODS OF CONTROLLING INSULIN MANAGEMENT FOR DELIVERING INSULIN DURING A FASTING PERIOD

#1190
US20230330336A1
Human necessities

SYSTEMS, DEVICES AND RELATED METHODS OF COORDINATING INSULIN MANAGEMENT AND DELIVERY MODES IN FASTING & NON-FASTING PERIODS

#1191
US20230330337A1
Human necessities

SYSTEM AND METHOD FOR CREATING OR ADJUSTING MANUAL BASAL PROFILES

#1192 ✅ Patent 12,186,535 granted on 2025-01-07
US20230330338A1
Human necessities

System and method for an injection using a syringe needle

#1193
US20230330339A1
Human necessities

ELECTRONIC MODULE AND AUTOINJECTOR

#1194
US20230330340A1
Human necessities

DISPOSABLE INJECTION NEEDLE

#1195
US20230330341A1
Human necessities

Auto-Injector System and Method

#1196
US20230330342A1
Human necessities

INJECTOR

#1197
US20230330343A1
Human necessities

SAFETY SYRINGE WITH FLEXIBLE RESERVOIR AND METHOD OF USE

#1198
US20230330344A1
Human necessities

SYRINGE WITH HIGH PULL-OUT RESISTANCE

#1199
US20230330345A1
Human necessities

DRUG DELIVERY DEVICE WITH ELECTRONIC SYSTEM

#1200 ✅ Patent 12,337,154 granted on 2025-06-24
US20230330346A1
Human necessities

Acoustic Detection of a Usage of an Injection Device